Back to Journals » Drug Design, Development and Therapy » Volume 5

Cabazitaxel: a novel second-line treatment for metastatic castration-resistant prostate cancer

Total article views   Abstract views HTML views PDF downloads Totals
38,181 Dovepress* 16,839 960+ 3,464 17,799
PubMed Central* 22 20,360 3,527 20,382
Totals 16,861 21,320 6,991 38,181
*Since 10 March 2011
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar